Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million
Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Mark…
CV
Practice Areas
Capital Markets and Public M&A
